Your browser doesn't support javascript.
loading
The Minimum Data Set and Quality Indicators for National Healthcare-Associated Infection Surveillance in Mainland China: Towards Precision Management.
Yao, Hongwu; Suo, Jijiang; Xing, Yubin; Du, Mingmei; Bai, Yanling; Liu, Bowei; Li, Lu; Huo, Rui; Lin, Jian; Chen, Chunping; Fu, Qiang; Liu, Yunxi.
Afiliação
  • Yao H; Department of Infection Management and Disease Control, Chinese PLA General Hospital, Beijing, China.
  • Suo J; Department of Infection Management and Disease Control, Chinese PLA General Hospital, Beijing, China.
  • Xing Y; Department of Infection Management and Disease Control, Chinese PLA General Hospital, Beijing, China.
  • Du M; Department of Infection Management and Disease Control, Chinese PLA General Hospital, Beijing, China.
  • Bai Y; Department of Infection Management and Disease Control, Chinese PLA General Hospital, Beijing, China.
  • Liu B; Department of Infection Management and Disease Control, Chinese PLA General Hospital, Beijing, China.
  • Li L; Department of Infection Management and Disease Control, Chinese PLA General Hospital, Beijing, China.
  • Huo R; HangZhou XingLin Information Technology CO., LTD, Hangzhou, China.
  • Lin J; HangZhou XingLin Information Technology CO., LTD, Hangzhou, China.
  • Chen C; HangZhou XingLin Information Technology CO., LTD, Hangzhou, China.
  • Fu Q; National Institute of Hospital Administration, Beijing, China.
  • Liu Y; Department of Infection Management and Disease Control, Chinese PLA General Hospital, Beijing, China.
Biomed Res Int ; 2019: 2936264, 2019.
Article em En | MEDLINE | ID: mdl-31360709
The magnitude and scope of the healthcare-associated infections (HCAIs) burden are underestimated worldwide, and have raised public concerns for their adverse effect on patient safety. In China, HCAIs still present an unneglected challenge and economic burden in recent decades. With the purpose of reducing the HCAI prevalence and enhancing precision management, China's National Nosocomial Infection Management and Quality Control Center (NNIMQCC) had developed a Minimum Data Set (MDS) and corresponding Quality Indicators (QIs) for establishing national HCAI surveillance system, the data elements of which were repeatedly discussed, investigated, and confirmed by consensus of the expert team. The total number of data elements in MDS and QIs were 70 and 64, and they were both classified into seven categorical items. The NNIMQCC also had started two pilot projects to inspect the applicability, feasibility, and reliability of MDS. After years of hard work, more than 400 health facilities in 14 provinces have realized the importance of HCAI surveillance and contributed to developing an ability of exporting automatically standardized data to meet the requirement of MDS and participate in the regional surveillance system. Generally, the emergence of MDS and QIs in China indicates the beginning of the national HCAI surveillance based on information technology and computerized process data. The establishment of MDS aimed to use electronic health process data to ensure the data accuracy and comparability and to provide instructive and ongoing QIs to estimate and monitor the burden of HCAIs, and to evaluate the effects of interventions and direct health policy decision-making.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Controle de Qualidade / Qualidade da Assistência à Saúde / Infecção Hospitalar / Monitoramento Epidemiológico / Instalações de Saúde Tipo de estudo: Prevalence_studies / Risk_factors_studies / Screening_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Biomed Res Int Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Controle de Qualidade / Qualidade da Assistência à Saúde / Infecção Hospitalar / Monitoramento Epidemiológico / Instalações de Saúde Tipo de estudo: Prevalence_studies / Risk_factors_studies / Screening_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Biomed Res Int Ano de publicação: 2019 Tipo de documento: Article